Mimedx (MDXG) Deferred Taxes (2016 - 2026)
Mimedx's (MDXG) quarterly Deferred Taxes came in at $4.5 million in Q1 2026, up 829.63% year-on-year from $487398.4 in Q1 2025, and up 320.92% quarter-over-quarter from -$2.1 million in Q4 2025.
Mimedx (MDXG) Deferred Taxes (2016 - 2026) Analysis & Trends
Mimedx has disclosed Deferred Taxes across 7 years of filings, most recently posting $4.5 million for Q1 2026.
- Deferred Taxes for Q1 2026 came in at $4.5 million, up 829.63% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.6 million (up 67.84% YoY), and the FY2025 annual result was -$8.7 million, up 30.16% from the prior year.
- Deferred Taxes came in at $4.5 million for Q1 2026 at Mimedx, up from -$2.1 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $37.8 million in Q4 2023 to a low of -$5.8 million in Q3 2025.
- The 4-year median for Deferred Taxes is -$2.0 million (2024), against an average of $2.1 million.
- Across the five-year window, Deferred Taxes slumped 106.16% in 2024 and surged 829.63% in 2026, its largest moves.
- Mimedx's Deferred Taxes stood at $37.8 million in 2023, then plunged by 106.16% to -$2.3 million in 2024, then rose by 11.97% to -$2.1 million in 2025, then jumped by 320.92% to $4.5 million in 2026.
- The last three Deferred Taxes figures came in at $4.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.53 Mn |
| Dec 31, 2025 | -2.05 Mn |
| Sep 30, 2025 | -5.75 Mn |
| Jun 30, 2025 | -287,000.00 |
| Mar 31, 2025 | -621,000.00 |
| Dec 31, 2024 | -2.33 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -5.31 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | 37.80 Mn |
| Dec 31, 2018 | 23.98 Mn |
| Sep 30, 2018 | 5.84 Mn |
| Jun 30, 2018 | -3.01 Mn |
| Mar 31, 2018 | -1.27 Mn |
| Dec 31, 2017 | -18.11 Mn |
| Sep 30, 2017 | -7.53 Mn |
| Jun 30, 2017 | -614,000.00 |
| Mar 31, 2017 | -416,000.00 |
| Dec 31, 2016 | -5.54 Mn |
| Sep 30, 2016 | -93,000.00 |